| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID4038: Therapeutics for people with COVID-19 |
|
Medicine details |
|
| Medicine name | casirivimab + imdevimab (Ronapreve®) |
| Formulation | 120 mg/ml, 120 mg/ml solution for injection/infusion |
| Reference number | 4956 |
| Indication | Prophylaxis and treatment of acute Covid-19 infection |
| Company | Roche Products Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/12/2021 |
| NICE guidance | |